Acute myocardial infarction

References

• Gruppo Italiano per lo Studio della Streptochinasl nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986: 1(8478): 397–402
   PubMed Web of Science ®Google Scholar
• International Study of Infarct Survival (ISIS) Steering Committee. Intravenous streptokinase given within 0–4 hours of onset of myocardial infarction reduces mortality in ISIS-2. Lancet 1987: 1 (8531): 502
   PubMed Web of Science ®Google Scholar
• AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988: 1 (8585): 545–9
   PubMed Web of Science ®Google Scholar
• Wilcox RG, von der Lippe G, Olsson CG, et al. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988: 2(8610): 525–30
   PubMed Web of Science ®Google Scholar
• Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. 1. Treatments following myocardial infarction. JAMA 1988: 260(14): 2088–93
   PubMed Web of Science ®Google Scholar
• Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. 2. Unstable angina, heart failure, primary prevention with aspirin and risk factor modification. JAMA 1988: 260(15): 2259–63
   PubMed Web of Science ®Google Scholar
• Killip T 3d, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol 1967: 20(4): 457–64
   PubMed Web of Science ®Google Scholar
• Lie KI, Liem KL, Louridtz WJ, et al. Efficacy of lidocaine in preventing primary ventricular fibrillation within 1 hour after a 300 mg intramuscular injection: a double-blind, randomized study of 300 hospitalized patients with acute myocardial infarction. Am J Cardiol 1978: 42(3): 486–8
   PubMed Web of Science ®Google Scholar
• MacMahon S, Collins R, Peto R, et al. Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized, controlled trials. JAMA 1988: 260(13): 1910–6
   PubMed Web of Science ®Google Scholar
• First International Study of Infarct Survival (ISIS-1) Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986: 2(8498): 57–66
   PubMed Web of Science ®Google Scholar
• First International Study of Infarct Survival (ISIS-1) Collaborative Group. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. Lancet 1988: 1(8591): 921–3
   PubMed Web of Science ®Google Scholar
• Mak IT, Weglicki WB. Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circ Res 1988: 63(1): 262–6
   PubMed Web of Science ®Google Scholar
• Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985: 27(5): 335–71
   PubMed Web of Science ®Google Scholar
• Goldman L, Sia ST, Cook EF, et al. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. N Engl J Med 1988: 319(3): 152–7
   PubMed Web of Science ®Google Scholar
• The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988: 319(7): 385–92
   PubMed Web of Science ®Google Scholar
• Reimer KA, Jennings RB. Effects of calcium-channel blockers on myocardial preservation during experimental acute myocardial infarction. Am J Cardiol 1985: 55(3): 107–15B
   PubMedGoogle Scholar
• Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction: results of a double-blind, randomized, multicenter trial. N Engl J Med 1986: 315(7): 423–9
   PubMed Web of Science ®Google Scholar
• Flaherty JT, Reid PR, Kelly DT, et al. Intravenous nitroglycerin in acute myocardial infarction. Circulation 1975: 51(1): 132–9
   PubMed Web of Science ®Google Scholar
• Come PC, Pitt B. Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction. Circulation 1976: 54(4): 624–8
   PubMed Web of Science ®Google Scholar
• Chiariello M, Gold HK, Leinbach RC, et al. Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction. Circulation 1976: 54(5): 766–73
   PubMed Web of Science ®Google Scholar
• Sharpe N, Murphy J, Smith H, et al. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1988: 1 (8580): 255–9
   PubMed Web of Science ®Google Scholar
• The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS), N Engl J Med 1987: 316(23): 1429–35
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Pfeffer JM, Steinberg C, et al. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with Captopril. Circulation 1985: 72(2): 406–12
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Lamas GA, Vaughan DE, et al. Effect of Captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988: 319(2): 80–6
   PubMed Web of Science ®Google Scholar
• McAlpine HM, Morton JJ, Leckie B, et al. Neuroendocrine activation after acute myocardial infarction. Br Heart J 1988: 60(2): 117–24
   PubMedGoogle Scholar
• Westlin W, Mullane K. Does Captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Circulation 1988: 77(6 Pt 2): 130–9
   Google Scholar
• Dzau VJ. Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol 1987: 59(2): 59–65A
   Google Scholar
• Come PC, Flaherty JT, Becker LC, et al. Combined administration of nitroglycerin and propranolol to patients with acute myocardial infarction. Chest 1981: 80(4): 416–24
   PubMed Web of Science ®Google Scholar
• Marchionni N, Pini R, Vannucci A, et al. Hemodynamic effects of digoxin in acute myocardial infarction in man: a randomized controlled trial. Am Heart J 1985: 109(1): 63–9
   PubMed Web of Science ®Google Scholar
• Coluccl WS, Wright RF, Braunwald E. New positive inotropic agents in the treatment of congestive heart failure: mechanisms of action and recent clinical developments. N Engl J Med 1986: 314(5): 290
   PubMed Web of Science ®Google Scholar
• Uretsky BF, Lawless CE, Verbalis JG, et al. Combined therapy with dobut-amine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy. Chest 1987: 92(4): 657–62
   PubMed Web of Science ®Google Scholar
• O'Neill WW, Topol EJ, Pitt B. Reperfusion therapy of acute myocardial infarction. Prog Cardiovasc Dis 1988: 30(4): 235–66
   PubMed Web of Science ®Google Scholar
• Lee L, Bates E, Pitt B, et al. Percutaneous transluminal coronary angioplasty improves survival in cardiogenic shock complicating acute myocardial infarction. Circulation (in press)
   Google Scholar
• Topol EJ, Califf RM, George BS, et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987: 317(10): 581–8
   PubMed Web of Science ®Google Scholar
• Simoons ML, Arnold AE, Betriu A, et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet 1988: 1(8579): 197–203
   PubMed Web of Science ®Google Scholar
• O'Neill W, Timmis GC, Bourdillon PD, et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med 1986: 314(13): 812–8
   PubMed Web of Science ®Google Scholar
• Topol EJ, Burek K, O'Neill WW, et al. A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. N Engl J Med 1988: 318(17): 1083–8
   PubMed Web of Science ®Google Scholar